Mangalam Drugs And Organics Limited (MANGALAM) reported revenue of ₹57.12 Cr and a net loss of ₹7.64 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
The statements below are read from Mangalam Drugs And Organics Limited’s filed results, 11 filed quarters and 3 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 13, 2026 · audited
| ₹ Cr | Sep2023 | Dec2023 | Mar2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026Latest | YoYlatest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 97.3 | 102 | 79.9 | 88.7 | 72.8 | 57.3 | 49.5 | 58.5 | 67.3 | 57.1 | -0.4% |
| Expenses | 0.00 | 90.4 | 90.5 | 71.2 | 79.9 | 62.5 | 61.8 | 52.4 | 59.9 | 72.9 | 56.2 | -9.1% |
| Operating profit | 0.00 | 6.98 | 11.7 | 8.70 | 8.77 | 10.3 | -4.48 | -2.84 | -1.43 | -5.62 | 0.90 | n/m |
| OPM % | — | 7.2% | 11.4% | 10.9% | 9.9% | 14.2% | -7.8% | -5.7% | -2.4% | -8.4% | 1.6% | +9.4 pp |
| Other income | 0.00 | 0.00 | 0.05 | 0.14 | 0.14 | -0.29 | 0.00 | 0.03 | 0.11 | 0.09 | 0.11 | n/m |
| Interest | 0.00 | 3.31 | 3.95 | 3.67 | 3.49 | 4.10 | 4.04 | 5.03 | 4.05 | 3.08 | 3.68 | -9.1% |
| Depreciation | 0.00 | 3.63 | 3.86 | 3.97 | 4.05 | 5.10 | 4.48 | 4.63 | 4.46 | 4.66 | 4.09 | -8.7% |
| Profit before tax | 0.00 | 0.04 | 3.93 | 1.20 | 1.37 | 1.85 | -13.0 | -12.5 | -9.84 | -13.3 | -6.75 | n/m |
| Tax % | n/a (loss) | — | 10.1% | — | 5.9% | 79.0% | n/a (loss) | n/a (loss) | n/a (loss) | n/a (loss) | n/a (loss) | — |
| Net profit | 0.00 | 0.50 | 3.53 | 2.69 | 1.29 | 0.34 | -13.8 | -7.35 | -9.84 | -13.4 | -7.64 | n/m |
| EPS (₹) | 0.00 | 0.31 | 2.23 | 1.70 | 0.81 | — | -8.72 | -4.64 | -6.21 | -8.48 | -4.83 | n/m |
